IMRN
Immuron Limited
NASDAQ · Healthcare · Biotechnology · AU
$1.80
+62.16%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.82x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 1.00x
Liquidity & coverage
- Current ratio
- 7.17x
- Quick ratio
- 5.90x
- Cash ratio
- 5.05x
- Interest coverage
- -610.22x
- EBITDA / interest
- -612.65x
- Working capital
- $7.9M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026